| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 11 |
| 1 | FLUDARABINE PHOSPHATE | 6 |
| 2 | DEFERASIROX | 5 |
| 3 | HYDROXYUREA | 5 |
| 4 | ALLOPURINOL | 4 |
| 5 | FILGRASTIM | 4 |
| 6 | GEMTUZUMAB OZOGAMICIN | 4 |
| 7 | PREDNISONE | 4 |
| 8 | VENETOCLAX | 4 |
| 9 | ACETAMINOPHEN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIFTOMENIB | 1 | 0.0135 |
| 1 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 2 | GEMTUZUMAB OZOGAMICIN | 4 | 0.0011 |
| 3 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 4 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 | 0.0008 |
| 5 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 6 | FOSINOPIRL SODIUM | 1 | 0.0005 |
| 7 | CLOFARABINE | 1 | 0.0004 |
| 8 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 9 | PILOCARPINE HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 1 | Corticosteroid [EPC] | 6 |
| 2 | Alkylating Drug [EPC] | 5 |
| 3 | Antimetabolite [EPC] | 5 |
| 4 | Iron Chelator [EPC] | 5 |
| 5 | Azole Antifungal [EPC] | 4 |
| 6 | BCL-2 Inhibitor [EPC] | 4 |
| 7 | CD33-directed Immunoconjugate [EPC] | 4 |
| 8 | Kinase Inhibitor [EPC] | 4 |
| 9 | Leukocyte Growth Factor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Menin Inhibitor [EPC] | 1 | 0.0135 |
| 1 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 3 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 4 | Iron Chelator [EPC] | 5 | 0.0002 |
| 5 | Cannabinoid [EPC] | 1 | 0.0001 |
| 6 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 9 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |